Stock listing
Cboe Canada:MDNA Medicenna Therapeutics Corp. Stock
Canadian listing (Cboe Canada) of Medicenna Therapeutics Corp. · home listing TSX:MDNA
Follow Medicenna Therapeutics Corp. into a list and get an email when it puts out news.
Home listing price · TSX:MDNA
$0.425 CAD -0.030 (-6.6%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSX:MDNA
- Day range
- $0.425 – $0.435 CADNov 2, 2026
- Volume
- 30,489 sharesNov 2, 2026
- Market cap
- $39.23M CADAt the close on Nov 2, 2026 · price × 92.30M shares outstanding
- 52-week range
- $0.335 – $1.780 CADLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $21,088 CADMedian day 33,215 shares · 1 day with no trades · last 3 months, Aug 4, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSX:MDNA · Home | $0.425 CAD | -0.030 (-6.6%) | 30,489 | $0.435 | $0.435 | $0.425 | $0.455 | Close on Nov 2, 2026 |
| OTC:MDNAF | $0.31 USD | -0.001 (-0.4%) | 15,000 | $0.31 | $0.31 | $0.31 | $0.311 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 2, 2026 · TSX:MDNA · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.425 | -0.030 | -6.6% | $0.435 | $0.435 | $0.425 | 30,489 | |
| $0.455 | -0.025 | -5.2% | $0.480 | $0.480 | $0.445 | 95,904 | |
| $0.480 | +0.025 | +5.5% | $0.455 | $0.480 | $0.455 | 160,487 | |
| $0.455 | +0.025 | +5.8% | $0.450 | $0.460 | $0.420 | 91,671 | |
| $0.430 | +0.010 | +2.4% | $0.420 | $0.445 | $0.420 | 16,606 | |
| $0.420 | -0.005 | -1.2% | $0.425 | $0.435 | $0.420 | 42,680 | |
| $0.425 | +0.005 | +1.2% | $0.420 | $0.445 | $0.420 | 33,215 | |
| $0.420 | +0.010 | +2.4% | $0.410 | $0.420 | $0.410 | 7,600 | |
| $0.410 | +0.020 | +5.1% | $0.390 | $0.425 | $0.385 | 89,300 | |
| $0.390 | -0.020 | -4.9% | $0.390 | $0.395 | $0.385 | 53,500 | |
| $0.410 | -0.040 | -8.9% | $0.450 | $0.450 | $0.385 | 96,800 | |
| $0.450 | +0.010 | +2.3% | $0.440 | $0.450 | $0.440 | 20,000 | |
| $0.440 | 0.000 | 0.0% | $0.445 | $0.445 | $0.440 | 10,700 | |
| $0.440 | +0.005 | +1.1% | $0.445 | $0.445 | $0.425 | 8,800 | |
| $0.435 | 0.000 | 0.0% | $0.450 | $0.460 | $0.435 | 94,400 | |
| $0.435 | -0.010 | -2.2% | $0.435 | $0.435 | $0.430 | 3,000 | |
| $0.445 | -0.005 | -1.1% | $0.450 | $0.460 | $0.430 | 44,700 | |
| $0.450 | +0.015 | +3.4% | $0.435 | $0.450 | $0.435 | 23,800 | |
| $0.435 | +0.025 | +6.1% | $0.400 | $0.470 | $0.395 | 325,400 | |
| $0.410 | +0.025 | +6.5% | $0.385 | $0.425 | $0.385 | 15,000 | |
| $0.385 | -0.005 | -1.3% | $0.400 | $0.400 | $0.385 | 31,400 | |
| $0.390 | +0.005 | +1.3% | $0.380 | $0.390 | $0.370 | 20,100 | |
| $0.385 | -0.010 | -2.5% | $0.385 | $0.400 | $0.380 | 82,500 | |
| $0.395 | 0.000 | 0.0% | $0.390 | $0.400 | $0.390 | 54,200 | |
| $0.395 | -0.010 | -2.5% | $0.405 | $0.405 | $0.395 | 6,800 | |
| $0.405 | 0.000 | 0.0% | $0.405 | $0.405 | $0.405 | 0 | |
| $0.405 | 0.000 | 0.0% | $0.405 | $0.410 | $0.405 | 1,500 | |
| $0.405 | -0.005 | -1.2% | $0.400 | $0.405 | $0.400 | 1,800 | |
| $0.410 | -0.015 | -3.5% | $0.415 | $0.415 | $0.410 | 34,300 | |
| $0.425 | 0.000 | 0.0% | $0.425 | $0.425 | $0.425 | 1,500 | |
| $0.425 | +0.020 | +4.9% | $0.415 | $0.430 | $0.410 | 39,700 | |
| $0.405 | +0.005 | +1.3% | $0.410 | $0.410 | $0.370 | 49,700 | |
| $0.400 | 0.000 | 0.0% | $0.395 | $0.400 | $0.380 | 80,700 | |
| $0.400 | -0.020 | -4.8% | $0.410 | $0.410 | $0.400 | 47,300 | |
| $0.420 | +0.005 | +1.2% | $0.430 | $0.430 | $0.410 | 7,300 | |
| $0.415 | -0.005 | -1.2% | $0.415 | $0.420 | $0.410 | 24,900 | |
| $0.420 | -0.010 | -2.3% | $0.430 | $0.430 | $0.420 | 29,400 | |
| $0.430 | -0.030 | -6.5% | $0.450 | $0.450 | $0.425 | 84,600 | |
| $0.460 | -0.010 | -2.1% | $0.470 | $0.470 | $0.450 | 16,300 | |
| $0.470 | 0.000 | 0.0% | $0.475 | $0.475 | $0.470 | 14,500 | |
| $0.470 | +0.010 | +2.2% | $0.465 | $0.480 | $0.465 | 33,800 | |
| $0.460 | -0.010 | -2.1% | $0.460 | $0.465 | $0.450 | 61,200 | |
| $0.470 | 0.000 | 0.0% | $0.475 | $0.480 | $0.460 | 23,100 | |
| $0.470 | -0.005 | -1.1% | $0.480 | $0.485 | $0.445 | 127,800 | |
| $0.475 | +0.015 | +3.3% | $0.475 | $0.480 | $0.475 | 9,200 | |
| $0.460 | -0.010 | -2.1% | $0.478 | $0.480 | $0.460 | 26,100 | |
| $0.470 | 0.000 | 0.0% | $0.480 | $0.490 | $0.470 | 73,800 | |
| $0.470 | +0.035 | +8.0% | $0.450 | $0.490 | $0.440 | 101,500 | |
| $0.435 | +0.025 | +6.1% | $0.415 | $0.455 | $0.415 | 36,700 | |
| $0.410 | -0.005 | -1.2% | $0.415 | $0.415 | $0.400 | 26,300 | |
| $0.415 | 0.000 | 0.0% | $0.435 | $0.435 | $0.405 | 25,700 | |
| $0.415 | -0.020 | -4.6% | $0.430 | $0.430 | $0.400 | 152,400 | |
| $0.435 | -0.005 | -1.1% | $0.440 | $0.440 | $0.425 | 32,100 | |
| $0.440 | -0.020 | -4.3% | $0.460 | $0.460 | $0.440 | 44,900 | |
| $0.460 | +0.060 | +15.0% | $0.410 | $0.460 | $0.410 | 125,900 | |
| $0.400 | -0.005 | -1.2% | $0.415 | $0.435 | $0.400 | 64,000 | |
| $0.405 | +0.005 | +1.3% | $0.405 | $0.410 | $0.400 | 11,500 | |
| $0.400 | +0.005 | +1.3% | $0.400 | $0.400 | $0.395 | 7,100 | |
| $0.395 | +0.020 | +5.3% | $0.390 | $0.395 | $0.380 | 27,400 | |
| $0.375 | -0.015 | -3.8% | $0.390 | $0.390 | $0.375 | 21,400 | |
| $0.390 | +0.010 | +2.6% | $0.400 | $0.400 | $0.375 | 41,400 | |
| $0.380 | +0.020 | +5.6% | $0.375 | $0.395 | $0.360 | 70,800 | |
| $0.360 | 0.000 | 0.0% | $0.365 | $0.370 | $0.335 | 49,800 |
- Ticker
- Cboe Canada:MDNA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Cboe Canada
- Currency
- CAD
What changed lately
Latest news release · Oct 26, 2026
Medicenna Reports Potent CD122 Blockade and Extended Survival with MDNA209 in Preclinical Models of Autoimmune Disease
Latest deck · September 2026
HC Wainwright 28th Annual Global Investment Conference 2026
Conference · 27 slides
Latest news
Medicenna Reports Potent CD122 Blockade and Extended Survival with MDNA209 in Preclinical Models of Autoimmune Disease
Oct 26, 2026
Closed $0.42 (-1.2%) on Oct 26, 2026
Medicenna to Present Preclinical Data on Its CD122 Superantagonist MDNA209 at The Promises of Treg and Interleukin-2 Therapies Conference
Oct 22, 2026
Closed $0.42 (+2.4%) on Oct 22, 2026
Medicenna Announces Oral Presentation of Topline Data from the Phase 1/2 ABILITY-1 Study of MDNA11 at SITC 2026
Oct 5, 2026
Closed $0.41 (+6.5%) on Oct 5, 2026
Medicenna Announces Results of Annual General and Special Meeting of Shareholders
Oct 1, 2026
Closed $0.385 (-1.3%) on Oct 2, 2026
Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting
Sep 24, 2026
Closed $0.405 (0.0%) on Sep 24, 2026
Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026
Closed $0.47 (+2.2%) on Sep 3, 2026
Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences
Aug 14, 2026
Closed $0.46 (+15.0%) on Aug 14, 2026
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
Jun 26, 2026
Closed $0.405 (-2.4%) on Jun 26, 2026
Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms
Jun 11, 2026
Closed $0.43 (+2.4%) on Jun 11, 2026
Medicenna's MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026
Jun 3, 2026
Closed $0.455 (+8.3%) on Jun 3, 2026
Decks
HC Wainwright 28th Annual Global Investment Conference 2026
Conference · 27 slides · September 2026
ESMO-IO Congress 2025
Conference · 27 slides · Dec 10, 2025
Investor Presentation (October 2025)
Investor deck · 24 slides · October 2025
Corporate Update (August 2022)
Corporate update · 10 slides · Aug 15, 2022
Medicenna Therapeutics Corp. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 28 in the last 12 months · 143 in all · newest Oct 26, 2026 · oldest 2017
- Decks
- 5 decks · latest September 2026
Where Medicenna Therapeutics Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSX:MDNA · Home listing | TSX | Canada | CAD |
| OTC:MDNAF | OTC | United States | USD |
| Cboe Canada:MDNA · This page | Cboe Canada | Canada | CAD |
Log in to ask 6ix AI your own questions about Medicenna Therapeutics Corp.